Compumedics revenues, losses up
03 September, 2003 by Melissa TrudingerCompumedics' (ASX:CMP) revenues for the 2002-2003 financial year were up 62 per cent to AUD$32 million, reflecting strong growth in the company's sleep diagnostics business.
Compumedics CEO earns entrepreneur award
26 August, 2003 by Melissa TrudingerCompumedics CEO David Burton has received an Entrepreneur of the Year award from global accounting firm Ernst and Young.
Gradipore board recruits former Sirtex CEO
26 August, 2003 by Melissa TrudingerFormer Sirtex Medical CEO Dr Colin Sutton has joined the board of Gradipore as a non-executive director.
Placement nets $10m for GTG
25 August, 2003 by Melissa TrudingerGenetic Technologies (ASX:GTG) has raised AUD$10 million in a share placement to institutional and professional investors, managed by Sydney boutique investment bank EG Capital.
PwC gives the nod to a biotech bounce
20 August, 2003 by Jeremy TorrA just-released BioForum report by business watchers PricewaterhouseCoopers has talked up the life sciences sector, based on a strong Q4 performance and positive investor sentiment thanks to better than average results compared to the five previous quarters.
Intel eyes the bio network
15 August, 2003 by Jeremy TorrThere are four big targets for computer companies when it comes to networked and clustered computers: energy; manufacturing, financial services – and bioinformatics, according to John Davies, general manager of eBiz channels and marketing at Intel.
Biotech a healthy market for chips
15 August, 2003 by Jeremy TorrIntel is looking hard at the emerging market of biotech devices.
Former BioComm VP moves to Select
08 August, 2003 by Melissa TrudingerDr Anthony Filippis, formerly of BioComm, has joined recently listed Select Vaccines as VP of business development.
Former Coles CEO joins Starpharma board
08 August, 2003 by Melissa TrudingerStarpharma has appointed prominent Melbourne businessman Peter Bartels as a director and chairman of its board of directors, replacing Richard Oliver, who has retired.
Expat to lead UK firms to AusBiotech conference
07 August, 2003 by Melissa TrudingerDelegates from 10 UK biotechnology companies will attend the upcoming AusBiotech 2003 conference in Adelaide, led by expatriate Australian Dr John Sime, currently the director of research support and development at Imperial College, London.
Sirtex records massive result, but Gray warns of slowdown
06 August, 2003 by Melissa TrudingerSirtex Medical has reported an increase in revenues of 1368 per cent, recording more than AUD$10 million in revenues for the 12 months ending June 30, and an after-tax profit of $3.15 million.
Iatia's cash flow prompts ASX query
05 August, 2003 by Melissa TrudingerMicroscopy company Iatia has received a 'please explain' from the Australian Stock Exchange after its fourth quarter results showed the company had a net negative operating cash flow for the quarter of AUD$671,000 and $296,000 cash remaining.
CSIRO adds commerce to board
04 August, 2003 by Jeremy TorrCSIRO has beefed up its board with two new non-executive members, one of whom -- Brian Keane -- is a former CEO of insurance giant AAMI. The other is Prof Alan Robson, vice-chancellor elect of the University of Western Australia.
NSW research review team named
01 August, 2003 by Jeremy TorrThe NSW government has named a team responsible for reviewing the state's overall medical and health research program.
Sydney Uni first in Aust to license GTG patents
29 July, 2003 by Melissa TrudingerThe University of Sydney has become the first research institution in Australia to be granted a non-exclusive research licence by Genetic Technologies (GTG) to use its controversial non-coding DNA patents.
